Injectable anaesthetics

SCANDINIBSA 3% SOLUTION FOR INJECTION

Provide your patients with extra care and attention with Scandinibsa 3%. With its mild vasodilating effect, mepivacaine can be used without a vasoconstrictor, still offering great performance. Recommended for patients in whom a vasoconstrictor is contraindicated and for dental procedures not requiring lengthy or profound pulpal anaesthesia. 

Brand names: SCANDINIBSA®, MEPIDENTAL®, MEPICART® & SCANDIVIN® 

Indications

SCANDINIBSA 3% SOLUTION FOR INJECTION is a local anaesthetic indicated for local and regional anaesthesia in dental procedures for adults, adolescents, and children over 4 years of age (with a body weight of approximately 20 kg).

Benefits

  • Glass cartridges
  • Latex-free plungers and caps
  • Inner and outer silicone coating
  • Plungers compatible with manual and self-aspirating syringes

Duration

ONSET OF ACTION: 3-5 min 

PULPAL ANAESTHESIA: Maxillary infiltration: 25 min; IANB: 40 min

SOFT TISSUE: Maxillary infiltration: 90 min; IANB: 165 min

Composition

Mepivacaine HCI 3%

Each ml contains:

  • Mepivacaine hydrochloride 30.00 mg

Presentation

Boxes of 50 or 100 cartridges of 1.8 ml (subject to market availability), with transparent blisters of 10 cartridges each.

Other names

SCANDINIBSA®, MEPIDENTAL®, MEPICART® & SCANDIVIN®

Uses

Infiltration and perineural use in the oral cavity. For use in dental anaesthesia only.

Single-use cartridges.